These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 19666316)
21. Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy. Felipo V; Urios A; Valero P; Sánchez M; Serra MA; Pareja I; Rodríguez F; Gimenez-Garzó C; Sanmartín J; Montoliu C Liver Int; 2013 Nov; 33(10):1478-89. PubMed ID: 23714168 [TBL] [Abstract][Full Text] [Related]
22. Minimal hepatic encephalopathy: A review. Nardone R; Taylor AC; Höller Y; Brigo F; Lochner P; Trinka E Neurosci Res; 2016 Oct; 111():1-12. PubMed ID: 27153746 [TBL] [Abstract][Full Text] [Related]
23. Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy? Quero Guillén JC; Groeneweg M; Jiménez Sáenz M; Schalm SW; Herrerías Gutiérrez JM Rev Esp Enferm Dig; 2002 Sep; 94(9):544-57. PubMed ID: 12587235 [TBL] [Abstract][Full Text] [Related]
24. Critical flicker frequency test for diagnosing minimal hepatic encephalopathy in patients with cirrhosis. Özel Coşkun BD; Özen M Turk J Gastroenterol; 2017 May; 28(3):191-196. PubMed ID: 28316320 [TBL] [Abstract][Full Text] [Related]
25. The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients. Giménez-Garzó C; Garcés JJ; Urios A; Mangas-Losada A; García-García R; González-López O; Giner-Durán R; Escudero-García D; Serra MA; Soria E; Felipo V; Montoliu C PLoS One; 2017; 12(2):e0171211. PubMed ID: 28146589 [TBL] [Abstract][Full Text] [Related]
26. Clinical and Neurologic Manifestation of Minimal Hepatic Encephalopathy and Overt Hepatic Encephalopathy. Basu PP; Shah NJ Clin Liver Dis; 2015 Aug; 19(3):461-72. PubMed ID: 26195201 [TBL] [Abstract][Full Text] [Related]
27. [Clinical importance and diagnostic methods of minimal hepatic encephalopathy]. Stawicka A; Zbrzeźniak J; Świderska A; Kilisińska N; Świderska M; Jaroszewicz J; Flisiak R Pol Merkur Lekarski; 2016 Feb; 40(236):117-21. PubMed ID: 27000818 [TBL] [Abstract][Full Text] [Related]
29. Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES). Badea MA; Drug VL; Dranga M; Gavrilescu O; Stefanescu G; Popa I; Mihai C; Cijevschi-Prelipcean C Metab Brain Dis; 2016 Dec; 31(6):1463-1471. PubMed ID: 27461111 [TBL] [Abstract][Full Text] [Related]
31. Diagnosis and Treatment of Low-Grade Hepatic Encephalopathy. Direkze S; Jalan R Dig Dis; 2015; 33(4):562-9. PubMed ID: 26159274 [TBL] [Abstract][Full Text] [Related]
32. Gut ammonia production and its modulation. Romero-Gómez M; Jover M; Galán JJ; Ruiz A Metab Brain Dis; 2009 Mar; 24(1):147-57. PubMed ID: 19067141 [TBL] [Abstract][Full Text] [Related]
33. Serum endotoxin, inflammatory mediators, and magnetic resonance spectroscopy before and after treatment in patients with minimal hepatic encephalopathy. Jain L; Sharma BC; Srivastava S; Puri SK; Sharma P; Sarin S J Gastroenterol Hepatol; 2013 Jul; 28(7):1187-93. PubMed ID: 23425082 [TBL] [Abstract][Full Text] [Related]
34. Quality of life in patients with minimal hepatic encephalopathy. Ridola L; Nardelli S; Gioia S; Riggio O World J Gastroenterol; 2018 Dec; 24(48):5446-5453. PubMed ID: 30622374 [TBL] [Abstract][Full Text] [Related]